Acute Porphyria Drug Database

Monograph

N01BA04 - Chloroprocaine
Propably not porphyrinogenic
PNP

Rationale
Chloroprocaine does not induce or inhibit any CYP enzymes, and no pharmacokinetic porphyrinogenic effects are suspected.
Chemical description
Chloroprocaine is an ester anesthetic, and is a derivative of benzoic acid.
Therapeutic characteristics
Chloroprocaine is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks (drugs.com, UpToDate) Choroprocain has a lower potential for systemic toxicity than other local anaesthetics, which allows a higher dosing. It has a fast onset of action, and a due to low protein binding it has a short duration (Columb 2010).
Metabolism and pharmacokinetics
Chloroprocaine is rapidly hydrolyzed by plasma enzymes to 2-chloro-4-aminobenzoic acid and beta-diethylaminoethanol. (Micromedex, Uptodate) Chloroprocaine is not metabolized by CYP enzymes, and is not suspected to interact with the CYP metabolism of other drugs (Lexi-Interact, Micromedex)

References

# Citation details PMID
*Scientific articles
1. Local anaesthetic agents. Anaesth Intensive Care. March 2010, Volume 11, Issue 3, Pages 113-117
Columb MO, Ramsaran R.
*Drug reference publications
2. [Chloroprocaine]. In: UpToDate. ((Accessed: 16. February 2018).
3. Chloroprocaine: Uses, Dosage & Side Effects. (Accessed: 16. February 2018).
4. Micromedex® 2.0 (online). Chloroprocaine (Drugdex System). (updated: 26.01.2018).
*Drug interaction databases
5. Lexi-Interact, via UpToDate.
6. Micromedex® 2.0 (online). Drug Interactions). (16.02.2018).

Similar drugs
Explore alternative drugs in similar therapeutic classes N01B / N01BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Ampres · Ampres 10 mg/ml oplossing voor injectie · Ampres 20 mg/ml oplossing voor injectie
Belgium
Ampres · Ampres 10 mg/ml sol. inj. i.théc. amp. · Ampres 20 mg/ml sol. inj. flac.
United Kingdom
Ampres · Ampres 400mg/20ml solution for injection vials · Ampres 50mg/5ml solution for injection ampoules
Denmark
Ampres
Norway
Ampres · Nesacaine-MPF
Poland
Ampres
Luxembourg
Ampres
Finland
Ampres
Latvia
Clorotekal
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙